Recommended pre-submission checks
Powered by 

Pediatric pharmacology Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Paediatrician Publishers, LLC |
| Language | English,Russian |
| Publication Time | 8 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English,Russian |
| Society/Institute/Sponsor | Union of Pediatricians of Russia |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Pediatric pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pediatric pharmacology
PARP1-specific inhibitor displays PARP1-detrapping activity.
- 19 May 2026
- Cell reports
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
- 19 May 2026
- Cell reports
Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.
- 19 May 2026
- Cell reports
High-resolution mapping of CCR4-NOT recruitment elements reveals transcriptome-wide drivers of mRNA decay.
- 18 May 2026
- Cell reports
A regulatory circuitry driving a noradrenergic to mesenchymal transition highlights YAP/TAZ as critical players in neuroblastoma plasticity.
- 18 May 2026
- Cell reports
Ki-67 promotes circulating tumor cell intravasation and metastasis in breast cancer.
- 15 May 2026
- Cell reports
PARP1-specific inhibitor displays PARP1-detrapping activity.
- 19 May 2026
- Cell reports
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
- 19 May 2026
- Cell reports
Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.
- 19 May 2026
- Cell reports
High-resolution mapping of CCR4-NOT recruitment elements reveals transcriptome-wide drivers of mRNA decay.
- 18 May 2026
- Cell reports
A regulatory circuitry driving a noradrenergic to mesenchymal transition highlights YAP/TAZ as critical players in neuroblastoma plasticity.
- 18 May 2026
- Cell reports
Ki-67 promotes circulating tumor cell intravasation and metastasis in breast cancer.
- 15 May 2026
- Cell reports